Pharming Group (PHGUF) News Today $1.00 0.00 (0.00%) As of 05/23/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock PHGUF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Pharming Group (PHGUF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth ...May 9, 2025 | uk.finance.yahoo.comPharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)April 25, 2025 | finance.yahoo.comPharming announces positive recommendation from NICE for JoenjaApril 24, 2025 | finance.yahoo.comPharming Group to report first quarter 2025 financial results on May 8April 24, 2025 | finance.yahoo.comPharming Group N.V.: Pharming receives positive recommendation from NICE for Joenja?(leniolisib) as a treatment for APDSApril 23, 2025 | finanznachrichten.dePharming Group (OTCMKTS:PHGUF) Short Interest Down 30.8% in MarchPharming Group (OTCMKTS:PHGUF - Get Free Report) was the target of a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 3,342,300 shares, a decline of 30.8% from the March 15th total of 4,828,600 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days. Approximately 0.5% of the shares of the company are short sold.April 20, 2025 | marketbeat.comPharming Group announces the filing of its 2024 Annual Report and Form 20-FApril 3, 2025 | finance.yahoo.comPharming Group (PHAR) Receives a Buy from H.C. WainwrightMarch 21, 2025 | markets.businessinsider.comPharming price target raised to $39 from $30 at OppenheimerMarch 14, 2025 | markets.businessinsider.comPharming Group (PHGUF) Projected to Post Quarterly Earnings on ThursdayPharming Group (OTCMKTS:PHGUF) will be releasing earnings on Thursday, March 13, Financial Modeling Prep reports.March 6, 2025 | marketbeat.comPharming Group N.V.: Pharming Group reports on results of the 2025 Extraordinary General Meeting of ShareholdersMarch 4, 2025 | finanznachrichten.dePharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percentFebruary 20, 2025 | uk.finance.yahoo.comPharming Group (OTCMKTS:PHGUF) Stock Passes Below 50-Day Moving Average - What's Next?Pharming Group (OTCMKTS:PHGUF) Stock Price Passes Below Fifty Day Moving Average - Here's What HappenedFebruary 13, 2025 | marketbeat.comPharming Group to participate in February investor conferenceFebruary 10, 2025 | finance.yahoo.comPharming Group (OTCMKTS:PHGUF) Share Price Passes Above 50-Day Moving Average - Here's WhyPharming Group (OTCMKTS:PHGUF) Shares Pass Above Fifty Day Moving Average - Here's WhyJanuary 23, 2025 | marketbeat.comPharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average - Time to Sell?Pharming Group (OTCMKTS:PHGUF) Share Price Passes Above 50 Day Moving Average - Should You Sell?December 27, 2024 | marketbeat.comPharming Group price target raised to EUR 2.15 from EUR 1.60 at RBC CapitalDecember 20, 2024 | markets.businessinsider.comPharming Group (OTCMKTS:PHGUF) Shares Up 10.6% - Here's WhyPharming Group (OTCMKTS:PHGUF) Shares Up 10.6% - Still a Buy?December 19, 2024 | marketbeat.comPharming Group Strengthens Pipeline with Abliva AcquisitionDecember 16, 2024 | msn.comPharming Group N.V. (PHAR)November 23, 2024 | finance.yahoo.comPharming price target lowered to $30 from $31 at OppenheimerOctober 28, 2024 | markets.businessinsider.comPharming Group’s Strong Q3 and CEO TransitionOctober 24, 2024 | msn.comPharming Group reports third quarter 2024 financial results and provides business updateOctober 24, 2024 | markets.businessinsider.comWhere Pharming Stands With AnalystsOctober 15, 2024 | benzinga.comPharming Group (OTCMKTS:PHGUF) Trading Up 13.5% - Should You Buy?Pharming Group (OTCMKTS:PHGUF) Stock Price Up 13.5% - Still a Buy?October 15, 2024 | marketbeat.comPharming Group to report third quarter 2024 financial results on October 24October 10, 2024 | markets.businessinsider.comOppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)September 28, 2024 | markets.businessinsider.comPharming announces marketing authorization in the U.K. for Joenja® (leniolisib)September 26, 2024 | finance.yahoo.comStrong Buy on Pharming Group: Robust Revenue Growth and Strategic Advancements Signal Sustained UpsideAugust 2, 2024 | markets.businessinsider.comPharming Group to report second quarter and first half 2024 financial results on August 1July 19, 2024 | finance.yahoo.comPharming Group (OTCMKTS:PHGUF) Sees Large Increase in Short InterestPharming Group (OTCMKTS:PHGUF - Get Free Report) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 5,830,500 shares, a growth of 23.7% from the April 30th total of 4,713,600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.June 2, 2024 | marketbeat.comPharming Group reports on results of the 2024 Annual General Meeting of ShareholdersMay 21, 2024 | finance.yahoo.comOrchard to lose out on milestone payments as Pharming Group ends collabMay 8, 2024 | bizjournals.comPharming Group N.V.April 28, 2024 | wsj.comPharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025April 19, 2024 | finance.yahoo.comPharming Group announces the placement of €100 million convertible bonds due 2029April 18, 2024 | finance.yahoo.comOptimistic Buy Rating on Pharming Group Backed by Promising Leniolisib Trials and Strategic Market ExpansionApril 8, 2024 | markets.businessinsider.comPharming Group N.V.: Pharming announces completion of enrollment in pediatric clinical trial of leniolisibApril 8, 2024 | finanznachrichten.dePharming Group announces the 2024 Annual General Meeting of ShareholdersApril 4, 2024 | finance.yahoo.comPharming Group to participate in April investor conferencesApril 3, 2024 | finance.yahoo.comPharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent ResultsMarch 17, 2024 | finance.yahoo.comPharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)March 16, 2024 | finance.yahoo.comPharming Group’s Strong Financial Performance and Growth Potential Merit Buy RatingMarch 15, 2024 | markets.businessinsider.comPharming Group to report fourth quarter and full year 2023 financial results on March 14February 29, 2024 | finance.yahoo.comPharming Group NV (PHAR)February 20, 2024 | uk.investing.comAnalysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Pharming Group (OtherPHGUF)January 12, 2024 | markets.businessinsider.comPharming Group N.V.: Pharming Group announces updated full year 2023 guidance and Joenja U.S. launch updateJanuary 8, 2024 | finanznachrichten.dePharming Group Projects 2023 Total Revenues To Rise 19%January 8, 2024 | markets.businessinsider.comPharming Group announces updated full year 2023 guidance and Joenja® U.S. launch updateJanuary 8, 2024 | finance.yahoo.comPharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisibNovember 21, 2023 | finance.yahoo.com Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter. Email Address PHGUF Media Mentions By Week PHGUF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHGUF News Sentiment▼0.000.75▲Average Medical News Sentiment PHGUF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHGUF Articles This Week▼00▲PHGUF Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MLTX News AMRX News OGN News HCM News XENE News MIRM News APLS News ARWR News NAMS News BLTE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PHGUF) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
